Skip to main content
Clinical Trials/CTRI/2020/10/028688
CTRI/2020/10/028688
Suspended
未知

A prospective open label clinical trial to evaluate the topical viral load reduction potential of ColloidalSilver (NanoAgCideTM) based hand sanitizer on SARS-CoV-2 infected subjects.

WeInnovate Biosolutions Pvt Ltd0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
WeInnovate Biosolutions Pvt Ltd
Status
Suspended
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
WeInnovate Biosolutions Pvt Ltd

Eligibility Criteria

Inclusion Criteria

  • 1\. Male or Female aged 18 to 80 years (both inclusive) of age tested SARS\-CoV\-2 positive within last
  • 8 days of study enrolment.
  • 2\. Patients willing to sign written informed consent and are ready to comply to study procedure.
  • 3\. SARS\-CoV\-2 positive asymptomatic or symptomatic patients who are under institutional
  • quarantine.

Exclusion Criteria

  • 1\. Patients requiring emergency treatment during enrolment.
  • 2\. Patients on ventilator support.
  • 3\. Pregnant or lactating woman.
  • 4\. Subjects with history of sun burn on hands.
  • 5\. Subjects with history of skin disorders or on medication for the same: Eczema, Urticaria, Psoriasis,
  • Herpes, skin cancer, Lupus, Vitiligo, Fungal infection, Candidiasis.
  • 6\. Subjects on treatment of any degree burns.
  • 7\. Any kind of psychiatric disorder or a condition in the opinion of the investigator may hinder
  • communication with the research team.
  • 8\. Inability of the subject to cooperate or communicate with the research team.

Outcomes

Primary Outcomes

Not specified

Similar Trials